Scholars Central

Short communicationPublished 2015

DHCR24: A Novel HCC Biomarker at a Glance

Authors: Khadija Rebbani, Kyoko Tsukiyama-Kohara

Clinical Microbiology: Open Access

Volume 4 · Issue 6 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The sustained increase of hepatocellular carcinoma (HCC) new cases and the failure of determining a “universal” biomarker for early detection are sounding the alarm about finding urgently new alternatives and develop new biomarkers in order to face this public health issue. Hereby, a highlight of new findings about the involvement of 3β-hydroxysterol Δ24-reductase (DHCR24) as a potential biomarker of hepatitis C disease progression to hepatocellular carcinoma and a valuable target for hepatitis C virus (HCV) related HCC therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Microbiology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Microbiology: Open Access
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Khadija Rebbani”
  • BylineArticles whose byline prints “Kyoko Tsukiyama-Kohara”